Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 25,115 | 41,463 | 26,607 | 26,384 | 24,724 |
| Gross Profit | 25,115 | 41,463 | 26,607 | 26,384 | 24,724 |
| Operating Expenses | 33,567 | 29,806 | 27,213 | 23,261 | 28,072 |
| Operating Income | -8,452 | 11,657 | -606 | 3,123 | -3,348 |
| Other Income | 1,969 | 2,183 | 2,512 | 2,692 | 2,261 |
| Pre-tax Income | -6,483 | 13,840 | 1,906 | 5,815 | -1,087 |
| Income Tax | 51 | 49 | 1,069 | 2,823 | N/A |
| Net Income Continuous | -6,534 | 13,791 | 837 | 2,992 | -1,087 |
| Net Income | $-6,534 | $13,791 | $837 | $2,992 | $-1,087 |
| EPS Basic Total Ops | -0.08 | 0.17 | 0.02 | 0.04 | -0.02 |
| EPS Basic Continuous Ops | -0.08 | 0.17 | 0.02 | 0.04 | -0.02 |
| EPS Diluted Total Ops | -0.08 | 0.17 | 0.02 | 0.04 | -0.02 |
| EPS Diluted Continuous Ops | -0.08 | 0.17 | 0.02 | 0.04 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.08 | 0.17 | 0.01 | N/A | N/A |
| EBITDA(a) | $-9,431 | $10,258 | $-2,346 | $1,674 | $-4,463 |